GSK
Haleon plans significant layoffs in the UK and elsewhere to save costs: report
Almost exactly one year after GSK’s consumer healthcare business spun off as Haleon, the company is reportedly implementing widespread layoffs ...
The first respiratory syncytial virus (RSV) vaccine for elderly people, GSK’s Arexvy, received approval from the Medicines and Healthcare Products Regulatory Agency
Source – GSK GSK has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...
Shingrix Granted Approval by Japan’s Ministry of Health Labour and Welfare for Shingles Prevention in At-Risk Individuals 18 Years and Older
Source – GSK On 26 June 2023, GSK announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has ...
Bellus Health Acquired by GSK is complete
Source – GSK On 28 June 2023, GSK and BELLUS Health announced the completion of GSK’s acquisition of BELLUS through ...
The FDA expedites the development of GSK’s vaccine for gonorrhea
Source – GSK GSK’s vaccine for gonorrhea has received a fast-track designation from the FDA, signaling its potential to combat ...
GSK Resolves First Jury Trial in Zantac Litigation Through Settlement
Source – GSK GSK has chosen to settle a significant lawsuit related to allegations that its drug Zantac caused cancer ...
CDC panel supports this year’s RSV vaccinations from GSK and Pfizer
If the Centres for Disease Control and Prevention (CDC) heed the counsel of professional advisers, adults in the US 60 ...
CDC advisory group reviews GSK and Pfizer RSV vaccinations
Source – Fierce Pharma On June 21, 2023, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease ...
Significant Surge in Biologic Medications for Lupus Treatment as Rheumatologists Shift Away from Traditional Off-Label Therapies
A recent analysis conducted by Spherix Global Insights reveals a notable increase in the utilization of new biologic drugs, namely ...
GSK Secures First Approval for RSV Vaccine in EU
The European Commission has given the green light for GSK’s Arexvy to be used in older adults aged 60 or ...
